BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 9384505)

  • 1. Aminoguanidine and the prevention of leukocyte dysfunction in diabetes mellitus: a direct vital microscopic study.
    Sannomiya P; Oliveira MA; Fortes ZB
    Br J Pharmacol; 1997 Nov; 122(5):894-8. PubMed ID: 9384505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ascorbic acid supplementation restores defective leukocyte-endothelial interaction in alloxan-diabetic rats.
    Zanardo RC; Costa Cruz JW; Oliveira MA; Fortes ZB
    Diabetes Metab Res Rev; 2003; 19(1):60-8. PubMed ID: 12592645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Minalrestat and leukocyte migration in diabetes mellitus.
    Cruz JW; Soto-Suazo MW; Hohman TC; Akamine EH; Zorn TT; Fortes ZB
    Diabetes Metab Res Rev; 2003; 19(3):223-31. PubMed ID: 12789656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of advanced glycation end products by aminoguanidine restores mast cell numbers and reactivity in alloxan-diabetic rats.
    Carvalho VF; Florim LT; de O Barreto E; Torres RC; Batista MM; Amendoeira FC; Cordeiro RS; Martins MA; E Silva PM
    Eur J Pharmacol; 2011 Nov; 669(1-3):143-8. PubMed ID: 21864526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of tolrestat on the defective leukocyte-endothelial interaction in experimental diabetes.
    Cruz JW; Oliveira MA; Hohman TC; Fortes ZB
    Eur J Pharmacol; 2000 Mar; 391(1-2):163-74. PubMed ID: 10720648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leukocyte-endothelial interaction is augmented by high glucose concentrations and hyperglycemia in a NF-kB-dependent fashion.
    Morigi M; Angioletti S; Imberti B; Donadelli R; Micheletti G; Figliuzzi M; Remuzzi A; Zoja C; Remuzzi G
    J Clin Invest; 1998 May; 101(9):1905-15. PubMed ID: 9576755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Probucol restores the defective leukocyte-endothelial interaction in experimental diabetes.
    Zanardo RC; Cruz JW; Martinez LL; de Oliveira MA; Fortes ZB
    Eur J Pharmacol; 2003 Oct; 478(2-3):211-9. PubMed ID: 14575807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of inhibition of glycation and oxidative stress on the development of cataract and retinal vessel abnormalities in diabetic rats.
    Agardh E; Hultberg B; Agardh C
    Curr Eye Res; 2000 Jul; 21(1):543-9. PubMed ID: 11035534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of long-term supplementation of vitamin C on leukocyte adhesion to the cerebral endothelium in STZ-induced diabetic rats.
    Jariyapongskul A; Patumraj S; Yamaguchi S; Niimi H
    Clin Hemorheol Microcirc; 2002; 27(1):67-76. PubMed ID: 12237491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Direct vital microscopic study of defective leukocyte-endothelial interaction in diabetes mellitus.
    Fortes ZB; Farsky SP; Oliveira MA; Garcia-Leme J
    Diabetes; 1991 Oct; 40(10):1267-73. PubMed ID: 1936589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Response of capillary cell death to aminoguanidine predicts the development of retinopathy: comparison of diabetes and galactosemia.
    Kern TS; Tang J; Mizutani M; Kowluru RA; Nagaraj RH; Romeo G; Podesta F; Lorenzi M
    Invest Ophthalmol Vis Sci; 2000 Nov; 41(12):3972-8. PubMed ID: 11053301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of diabetes and aminoguanidine treatment on endothelial function in a primate model of type 1 diabetes.
    Brooks BA; Heffernan S; Thomson S; McLennan SV; Twigg SM; Yue DK
    Am J Primatol; 2008 Aug; 70(8):796-802. PubMed ID: 18481256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene expression of receptor for advanced glycosylation end products and its modulation by aminoguanidine in diabetic kidney tissue.
    Huang Y; Lin S; Zhou J
    Chin Med J (Engl); 1998 Aug; 111(8):698-704. PubMed ID: 11245022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aminoguanidine prevents arterial stiffening in a new rat model of type 2 diabetes.
    Chang KC; Tseng CD; Wu MS; Liang JT; Tsai MS; Cho YL; Tseng YZ
    Eur J Clin Invest; 2006 Aug; 36(8):528-35. PubMed ID: 16893374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PKC-beta inhibitor (LY333531) attenuates leukocyte entrapment in retinal microcirculation of diabetic rats.
    Nonaka A; Kiryu J; Tsujikawa A; Yamashiro K; Miyamoto K; Nishiwaki H; Honda Y; Ogura Y
    Invest Ophthalmol Vis Sci; 2000 Aug; 41(9):2702-6. PubMed ID: 10937586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Morphine attenuates leukocyte/endothelial interactions.
    Ni X; Gritman KR; Eisenstein TK; Adler MW; Arfors KE; Tuma RF
    Microvasc Res; 2000 Sep; 60(2):121-30. PubMed ID: 10964586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of tumor necrosis factor-alpha-induced intercellular adhesion molecule-1 expression in diabetic rats: role of insulin.
    Anjos-Valotta EA; Martins JO; Oliveira MA; Casolari DA; Britto LR; Tostes RC; Fortes ZB; Sannomiya P
    Inflamm Res; 2006 Jan; 55(1):16-22. PubMed ID: 16328103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of the natural flavonoid delphinidin on diabetic microangiopathy.
    Bertuglia S; Malandrino S; Colantuoni A
    Arzneimittelforschung; 1995 Apr; 45(4):481-5. PubMed ID: 7779146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitory effect of locally administered heparin on leukocyte rolling and chemoattractant-induced firm adhesion in rat mesenteric venules in vivo.
    Xie X; Thorlacius H; Raud J; Hedqvist P; Lindbom L
    Br J Pharmacol; 1997 Nov; 122(5):906-10. PubMed ID: 9384507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of advanced glycation end-products protects against retinal capillary basement membrane expansion during long-term diabetes.
    Gardiner TA; Anderson HR; Stitt AW
    J Pathol; 2003 Oct; 201(2):328-33. PubMed ID: 14517851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.